Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_assertion type Assertion NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_head.
- NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_provenance.
- NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_assertion evidence source_evidence_literature NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_provenance.
- NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_assertion SIO_000772 20881489 NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_provenance.
- NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_assertion wasDerivedFrom befree-2016 NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_provenance.
- NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_assertion wasGeneratedBy ECO_0000203 NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_provenance.